ProCE Banner Activity

LATTE: Durable Viral Suppression With Oral Cabotegravir + Rilpivirine Maintenance Therapy Through Wk 312

Slideset Download
Conference Coverage
Final analysis of this phase IIb study observes that oral cabotegravir plus rilpivirine maintenance regimen provides durable virologic suppression.

Released: November 18, 2019

Share

Provided by

Provided by the USF Health
ProCE Banner

Supporters

Supported by educational grants from

Gilead

Janssen Therapeutics Division of Janssen Products

ViiV Healthcare